@FiercePharma: Biopharma's 20 highest-paid CEOs. Our latest special report on exec pay. Report | Follow @FiercePharma
@EricPFierce: AstraZeneca rides Crestor to top of cardio drug list. Special report | Follow @EricPFierce
> Kentucky's attorney general has added his lawsuit to the list of state claims filed against Johnson & Johnson ($JNJ) alleging illegal marketing of its Risperdal antipsychotic drug.
> Novartis ($NVS) said its Afinitor cancer treatment extended progression-free survival in women with HER2 positive breast cancer when used in combination with Roche's ($RHHBY) Herceptin and the chemo drug vinorelbine, compared with patients on Herceptin and vinorelbine alone. Release
> Chugai Pharmaceutical CEO Osamu Nagayama is said to be getting a new post: chairman of Sony Corp. Report
> The new "bible" of psychiatry, the controversial fifth version of the Diagnostic and Statistical Manual of Mental Disorders, may find itself less influential than previous editions, particularly in research. Report
> Teva Pharmaceutical Industries ($TEVA) is trying to keep clear of the political controversy surrounding its Plan B contraceptive and girls' access to it. Report
Medical Device News
@FierceMedDev: Shoe-mounted lever could power artificial heart pumps. More | Follow @FierceMedDev
@MarkHFierce: Check out FierceDrugDelivery's latest - a great look at some advances in nanotech drug delivery. Special report | Follow @MarkHFierce
@DamianFierce: PRA is lining up to go public, filing a confidential draft with the SEC. Article | Follow @DamianFierce
> FDA slaps deadly label on Abbott's glucose meter recall. News
> PIP attorneys plead for leniency in breast implant fraud trial. Report
> Medtronic wins CE mark for clot-removal tech. More
Biotech News
@FierceBiotech: Life sciences VC firm launches 'crowdfunding' site for limited crowd. More | Follow @FierceBiotech
@JohnCFierce: Pentagon advisor pocketed biotech's cash while promoting its interests - via LATimes. Report | Follow @JohnCFierce
@RyanMFierce: Interesting 'Open Research Exchange' platform debuts for creating outcome measures from the crowd. Release | Follow @RyanMFierce
> Pentagon adviser quietly pocketed biotech's cash while promoting its interests. Story
> Elan orchestrates $693M biotech buyout, $90M spinout in deal frenzy. Report
> Effector Therapeutics snags $45M venture round from A-list backers. News
CRO News
> Nordion inks CMO deal with Navidea. Report
> After successful IPO, Quintiles plots 400 job cuts. Item
> PRA winds up for IPO. News
> Quintiles signs on to help Merck KGaA right the R&D ship. More
> PPD's BioDuro opens Shanghai discovery lab. Story
>WuXi's revenue jumps 11.7% in strong Q1. Article
Biotech IT News
> Drugmaker UCB taps IBM for digital medicine effort. Article
> InSilico Genomics grabs $1.5M for fledgling bioinformatics biz. Report
> Life sciences VC firm launches 'crowdfunding' site for limited crowd. Article
> Sanofi hunts for clinical trial recruits in growing social network. Story
> Merck targets docs with revamped U.K. website and healthcare apps. News
And Finally... U.K. Health Secretary Jeremy Hunt called for international action to deal with the soaring number of antibiotic-resistant infections. Release